ResearcherUniversity at Buffalo, State University of New YorkNo recent work listed

Dipti K. Pawaskar

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5036571931. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2013: 2 papers

Papers 2

Synergistic interactions between sorafenib and everolimus in pancreatic cancer xenografts in mice. Co-author DOI 10.1007/s00280-013-2117-x ↗
Interactions of everolimus and sorafenib in pancreatic cancer cells. Co-author DOI 10.1208/s12248-012-9417-7 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Robert M. Straubinger · 2 shared papers, 2013 · strength 0.09
- Paper Interactions of everolimus and sorafenib in pancreatic cancer cells. DOI 10.1208/s12248-012-9417-7 ↗
- Paper Synergistic interactions between sorafenib and everolimus in pancreatic cancer xenografts in mice. DOI 10.1007/s00280-013-2117-x ↗
William J. Jusko · 2 shared papers, 2013 · strength 0.09
- Paper Interactions of everolimus and sorafenib in pancreatic cancer cells. DOI 10.1208/s12248-012-9417-7 ↗
- Paper Synergistic interactions between sorafenib and everolimus in pancreatic cancer xenografts in mice. DOI 10.1007/s00280-013-2117-x ↗
Wen Wee Ma · 2 shared papers, 2013 · strength 0.09
- Paper Interactions of everolimus and sorafenib in pancreatic cancer cells. DOI 10.1208/s12248-012-9417-7 ↗
- Paper Synergistic interactions between sorafenib and everolimus in pancreatic cancer xenografts in mice. DOI 10.1007/s00280-013-2117-x ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.